Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06325397 · ClinicalTrials.gov registry record

Less Discomfort and Less Pharmacology. Cataract Surgery at Physiologic Intraocular Pressure (IOP)

A clinical trial of Nuclear Cataract, sponsored by Matthew Rauen.

Completed
Registry status
65
Enrollment target
1
Study location

NCT06325397: Completed study of Nuclear Cataract, sponsored by Matthew Rauen.

NCT06325397 is a study of Nuclear Cataract that has completed, run by Matthew Rauen. The registered enrollment target is 65 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06325397, a study of Nuclear Cataract, has completed, sponsored by Matthew Rauen.

COMPLETED
Registry status
65 participants
Enrollment target
1
Study location

Study Summary

To investigate the impact of high vs low Intraocular Pressure (IOP) on the intraoperative experience for the patient and surgeon. Operating at a more physiologic IOP using Active Sentry hand piece during cataract surgery will result in significantly less discomfort/pain as assessed by the decreased need for rescue medication

Primary Outcome

Percentage (%) of pts in each group requiring treatment for breakthrough discomfort/pain

Conditions Studied

Interventions

  • OTHER High Intraocular Pressure (IOP)
  • OTHER Low Intraocular Pressure (IOP)

Study Locations (1)

Iowa

  • Wolfe Eye Clinic - West Des Moines

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2024-03-18
Est. Completion 2025-04-01
Matthew Rauen

3 total trials

What the finished NCT06325397 record still lists

NCT06325397 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 65 participants, a relatively small participant target.

The record links to 1 condition, with Nuclear Cataract appearing as the primary indexed condition, and to 2 interventions - of which High Intraocular Pressure (IOP) is the first listed.

NCT06325397 reports a single indexed study location in Iowa.

Frequently Asked Questions

What is clinical trial NCT06325397 about?

NCT06325397 is a clinical study titled "Less Discomfort and Less Pharmacology. Cataract Surgery at Physiologic Intraocular Pressure (IOP)". To investigate the impact of high vs low Intraocular Pressure (IOP) on the intraoperative experience for the patient and surgeon. Operating at a more physiologic IOP using Active Sentry hand piece during cataract surgery will result in significantly less discomfort/pain as assessed by the decreased ...

What is the current status of trial NCT06325397?

This trial is currently completed. The enrollment target is 65 participants. The study started on 2024-03-18. Estimated completion is 2025-04-01.

What conditions does trial NCT06325397 study?

This clinical trial studies the following conditions: Nuclear Cataract.

What interventions are being tested in trial NCT06325397?

The interventions under investigation include: High Intraocular Pressure (IOP) (OTHER), Low Intraocular Pressure (IOP) (OTHER).

Who is sponsoring clinical trial NCT06325397?

This trial is sponsored by Matthew Rauen, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06325397 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03366116 · 65 participants · Phase 1

    5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors

  • NCT03603730 · 65 participants · NA

    Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis

  • NCT03796559 · 65 participants · NA

    Magseed Enabled Long-Term Localization of Axillary Lymph Nodes

  • NCT03993106 · 65 participants · Phase 2

    A Study of sEphB4-HSA in Kaposi Sarcoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06325397, the US trial registry maintained by the National Library of Medicine. NCT06325397 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.